Abstract

Influenza is a cause of hospitalization and mortality in infants. γδ T cells are the first T cells to develop during embryogenesis and are a significant component of the neonatal immune system. In the neonatal period, conventional αβ T cell responses are functionally less prominent. γδ T cells play critical regulatory and effector roles, but their relevance in neonatal influenza remains to be investigated. In our neonatal infection model, we found γδ T cells were protective against mortality associated with neonatal influenza infection. Infection induced the accumulation of γδ T cells, which transiently expressed IL-17a, rather than IFN-γ. Subsequently, this led to stronger Type 2 immune responses than the TCRδ-deficient animals, particularly in IL-33 production and amphiregulin-mediated tissue repair. Loss of γδ T cells did not alter viral clearance or conventional anti-viral responses. We also observed an association between IL-17a levels and clinical outcomes. Thus, our results identify a specific requirement for γδ T cells in influenza-infected neonates for initiating Type 2 immune responses, mediating tissue homeostasis, and promoting lung integrity, which may provide a new therapeutic target for pediatric influenza treatment.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/pages/standard-publication-reuse-rights)
You do not currently have access to this article.